Clinical proof of concept through a randomised phase II study: a combination of immunotherapy and stereotactic ablative radiotherapy as a curative treatment for limited metastatic lung cancer

Livrables

Publications

Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study

Auteurs: Evert Jan Van Limbergen, Ann Hoeben, Relinde I.Y. Lieverse, Ruud Houben, Chantal Overhof, Alida Postma, Jaap Zindler, Frans Verhelst, Ludwig J. Dubois, Dirk De Ruysscher, Esther G.C. Troost, Philippe Lambin
Publié dans: International Journal of Radiation Oncology*Biology*Physics, Numéro 109/5, 2021, Page(s) 1421-1430, ISSN 0360-3016
Éditeur: Elsevier BV
DOI: 10.1016/j.ijrobp.2020.11.053

Releasing the brakes of tumor immunity with anti-PD-L1 and pushing its accelerator with L19–IL2 cures poorly immunogenic tumors when combined with radiotherapy

Auteurs: Veronica Olivo Pimentel, Damiënne Marcus, Alexander MA van der Wiel, Natasja G Lieuwes, Rianne Biemans, Relinde IY Lieverse, Dario Neri, Jan Theys, Ala Yaromina, Ludwig J Dubois, Philippe Lambin
Publié dans: Journal for ImmunoTherapy of Cancer, Numéro 9/3, 2021, Page(s) e001764, ISSN 2051-1426
Éditeur: BMJ
DOI: 10.1136/jitc-2020-001764

A prediction model for early death in non-small cell lung cancer patients following curative-intent chemoradiotherapy

Auteurs: Arthur Jochems, Issam El-Naqa, Marc Kessler, Charles S. Mayo, Shruti Jolly, Martha Matuszak, Corinne Faivre-Finn, Gareth Price, Lois Holloway, Shalini Vinod, Matthew Field, Mohamed Samir Barakat, David Thwaites, Dirk de Ruysscher, Andre Dekker, Philippe Lambin
Publié dans: Acta Oncologica, Numéro 57/2, 2017, Page(s) 226-230, ISSN 0284-186X
Éditeur: Taylor & Francis
DOI: 10.1080/0284186X.2017.1385842

18F-fluorodeoxyglucose positron-emission tomography (FDG-PET)-Radiomics of metastatic lymph nodes and primary tumor in non-small cell lung cancer (NSCLC) – A prospective externally validated study

Auteurs: Sara Carvalho, Ralph T. H. Leijenaar, Esther G. C. Troost, Janna E. van Timmeren, Cary Oberije, Wouter van Elmpt, Lioe-Fee de Geus-Oei, Johan Bussink, Philippe Lambin
Publié dans: PLOS ONE, Numéro 13/3, 2018, Page(s) e0192859, ISSN 1932-6203
Éditeur: Public Library of Science
DOI: 10.1371/journal.pone.0192859

Human fibronectin extra domain B as a biomarker for targeted therapy in cancer

Auteurs: Relinde I. Y. Lieverse, Damiënne Marcus, Alexander M. A. Wiel, Evert J. Van Limbergen, Jan Theys, Ala Yaromina, Philippe Lambin, Ludwig J. Dubois
Publié dans: Molecular Oncology, 2020, ISSN 1574-7891
Éditeur: Elsevier BV
DOI: 10.1002/1878-0261.12705

Will immunotherapy really change radiotherapy?

Auteurs: Lambin, P., Lieverse, R., Baumann, M., Ebert, N.
Publié dans: The Lancet Oncology, Numéro 20/12, 2019, Page(s) 1642-1644, ISSN 1470-2045
Éditeur: The Lancet Publishing Group
DOI: 10.1016/s1470-2045(19)30682-5

Stereotactic ablative body radiotherapy (SABR) combined with immunotherapy (L19-IL2) versus standard of care in stage IV NSCLC patients, ImmunoSABR: a multicentre, randomised controlled open-label phase II trial

Auteurs: Relinde I. Y. Lieverse, Evert J. Van Limbergen, Cary J. G. Oberije, Esther G. C. Troost, Sine R. Hadrup, Anne-Marie C. Dingemans, Lizza E. L. Hendriks, Franziska Eckert, Crispin Hiley, Christophe Dooms, Yolande Lievens, Monique C. de Jong, Johan Bussink, Xavier Geets, Vincenzo Valentini, Giuliano Elia, Dario Neri, Charlotte Billiet, Amir Abdollahi, David Pasquier, Pierre Boisselier, Ala Yaromina,
Publié dans: BMC Cancer, Numéro 20/1, 2020, ISSN 1471-2407
Éditeur: BioMed Central
DOI: 10.1186/s12885-020-07055-1

Lymphocyte-Sparing Radiotherapy: The Rationale for Protecting Lymphocyte-rich Organs When Combining Radiotherapy With Immunotherapy

Auteurs: Philippe Lambin, Relinde I.Y. Lieverse, Franziska Eckert, Damiënne Marcus, Cary Oberije, Alexander M.A. van der Wiel, Chandan Guha, Ludwig J. Dubois, Joseph O. Deasy
Publié dans: Seminars in Radiation Oncology, Numéro 30/2, 2020, Page(s) 187-193, ISSN 1053-4296
Éditeur: W. B. Saunders Co., Ltd.
DOI: 10.1016/j.semradonc.2019.12.003

Structural and functional radiomics for lung cancer

Auteurs: G.Y. Wu, A. Jochems, T. Refaee, A. Ibrahim, C.G. Yan, S. Sanduleanu, H.C. Woodruff, P. Lambin
Publié dans: European Journal of Nuclear Medicine and Molecular Imaging, 2021, Page(s) 3961-3974, ISSN 1619-7089
Éditeur: Springer Link
DOI: 10.1007/s00259-021-05242-1

Non-invasive imaging prediction of tumor hypoxia: A novel developed and externally validated CT and FDG-PET-based radiomic signatures

Auteurs: Sebastian Sanduleanu, Arthur Jochems, Taman Upadhaya, Aniek J.G. Even, Ralph T.H. Leijenaar, Frank J.W.M. Dankers, Remy Klaassen, Henry C. Woodruff, Mathieu Hatt, Hans J.A.M. Kaanders, Olga Hamming-Vrieze, Hanneke W.M. van Laarhoven, Rathan M. Subramiam, Shao Hui Huang, Brian O'Sullivan, Scott V. Bratman, Ludwig J. Dubois, Razvan L. Miclea, Dario Di Perri, Xavier Geets, Mireia Crispin-Ortuzar, Adi
Publié dans: Radiotherapy and Oncology, Numéro 153, 2020, Page(s) 97-105, ISSN 0167-8140
Éditeur: Elsevier BV
DOI: 10.1016/j.radonc.2020.10.016

Automated detection and segmentation of non-small cell lung cancer computed tomography images

Auteurs: S.P. Primakov, A. Ibrahim, J.E. van Timmeren, G.Y. Wu, S.A. Keek, M. Beuque, R.W.Y. Granzier, E. Lavrova, M. Scrivener, S. Sanduleanu, E. Kayan, I. Halilaj, Anouk Lenaers, J.L. Wu, R. Monshouwer, X. Geets, H.A. Gietema, L.E.L. Hendriks, O. Morin, A. Jochems, H.C. Woodruff, P. Lambin
Publié dans: Nature Communications, Numéro 3423, 2022, ISSN 2041-1723
Éditeur: Nature Publishing Group
DOI: 10.1038/s41467-022-30841-3

Livrables

Publications

Partager cette page

Télécharger